0
6 FDA Panel Rejects Vivus Weight Loss Drug Qnexa   Wall Street Journal
Gossip Jackal
 FDA Panel Rejects Vivus Weight Loss Drug Qnexa   Wall Street Journal
FDA Panel Rejects Vivus Weight-Loss Drug Qnexa
Wall Street Journal
Most panel members were also part of the Avandia panel that met earlier this week to discuss whether to keep that drug on the market amid concerns that the
Arena Pharma Rallies On FDA Optimism; Vivus Shares HaltedWall Street Journal
Vivus' Qnexa takes center stage during panel reviewFierceBiotech
3 New Weight Loss Drugs Waiting for FDA OKsADI News (blog)
MarketWatch
all 316 news articles »

Share and Enjoy:
  • Digg
  • del.icio.us
  • Facebook
  • NewsVine
  • Reddit
  • StumbleUpon
  • Google Bookmarks
  • Yahoo! Buzz
  • Twitter
  • Technorati
  • Live
  • LinkedIn
  • MySpace

Leave a Reply

Security Code: